Zoetis Receives USDA License for Poulvac® Procerta® HVT-ND-ILT Vaccine for Chickens
Business Wire•19/11/2026•07:30 ET
0
Key Highlights
- ➤Zoetis (ZTS) receives USDA license for Poulvac Procerta HVT-ND-ILT vaccine.
- ➤Poulvac Procerta HVT-ND-ILT targets Marek’s, Newcastle and infectious laryngotracheitis diseases.
- ➤Vaccine is labeled for healthy one-day-old chickens or 18- to 19-day-old embryonated eggs.
- ➤Product expands poultry vaccination options, including seasonal or rotational ILT programs.
Expert Statements
Abhay Nayak, Executive Vice President and President, U.S. Commercial Operations at Zoetis
“The USDA license is an important achievement for our poultry business and reflects Zoetis’ commitment to advancing practical solutions for customers.”
Abhay Nayak, Executive Vice President and President, U.S. Commercial Operations at Zoetis
“Poulvac Procerta HVT-ND-ILT adds a new option to our portfolio, giving veterinarians and producers more flexibility to tailor their vaccination strategies.”
Abhay Nayak, Executive Vice President and President, U.S. Commercial Operations at Zoetis
“Our team looks forward to working with customers as they consider how it may support their flock-health programs.”
Zoetis Receives USDA License for Poulvac® Procerta® HVT-ND-ILT Vaccine for Chickens
3-in-1 vector vaccine expands disease-protection options for chickens, backed by Zoetis’ comprehensive vaccine portfolio and specialized expertise
Get started
Create a free account to read the full story.
